Schonfeld Strategic Advisors’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-5,580	Closed	-$1.85M	–	2342
2025 Q1	$1.85M	Buy	5,580 +55	+1%	+$18.1K	0.01%	1002
2024 Q4	$1.7M	Sell	5,525 -40,569	-88%	-$11.4M	0.01%	897
2024 Q3	$9.78M	Buy	46,094 +21,634	+88%	+$5.53M	0.08%	307
2024 Q2	$6.85M	Buy	+24,460	New	+$5.82M	0.05%	469
2024 Q1	–	Sell	-12,458	Closed	-$2.88M	–	2275
2023 Q4	$2.88M	Sell	12,458 -59,077	-83%	-$10.3M	0.02%	684
2023 Q3	$10.4M	Buy	71,535 +51,670	+260%	+$9.73M	0.1%	340
2023 Q2	$4.59M	Sell	19,865 -9,939	-33%	-$2.69M	0.04%	513
2023 Q1	$7.22M	Buy	29,804 +15,204	+104%	+$4.14M	0.07%	354
2022 Q4	$4.24M	Sell	14,600 -54,136	-79%	-$5.29M	0.04%	529
2022 Q3	$4.46M	Buy	68,736 +56,389	+457%	+$3.92M	0.04%	564
2022 Q2	$884K	Buy	+12,347	New	+$908K	0.01%	1079
2022 Q1	–	Sell	-8,905	Closed	-$754K	–	2802
2021 Q4	$754K	Buy	8,905 +3,105	+54%	+$255K	0.01%	1066
2021 Q3	$463K	Sell	5,800 -400	-6%	-$34.5K	0.01%	1310
2021 Q2	$604K	Sell	6,200 -24,254	-80%	-$2.87M	0.01%	1104
2021 Q1	$3.56M	Buy	+30,454	New	+$3.55M	0.05%	525
2020 Q4	–	Sell	-6,507	Closed	-$773K	–	1751
2020 Q3	$773K	Sell	6,507 -1,378	-17%	-$150K	0.02%	778
2020 Q2	$893K	Sell	7,885 -36	-0.5%	-$3.54K	0.02%	626
2020 Q1	$529K	Buy	+7,921	New	+$660K	0.03%	561
2019 Q2	–	Sell	-2,700	Closed	-$338K	–	1154
2019 Q1	$338K	Sell	2,700 -28,200	-91%	-$3.51M	0.01%	803
2018 Q4	$3.48M	Sell	30,900 -29,000	-48%	-$4.49M	0.13%	216
2018 Q3	$12.8M	Buy	59,900 +54,000	+915%	+$13.6M	0.57%	26
2018 Q2	$1.65M	Buy	5,900 +2,108	+56%	+$370K	0.09%	304
2018 Q1	$443K	Buy	+3,792	New	+$468K	0.03%	502